EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Circulating Butyrate Attenuates Cetuximab Efficacy in Colorectal Cancer Through EGFR and AMPK–Wip1 Signaling

Jiayao Zhang, Mingqing Zhang iD, Xiaojing Wu, Haoren Jing, Peiran Li, Wei Wang, Xi Guo, Zhenying Zhao, Siwei Zhu, Yijia Wang iD

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s574116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Jiayao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin, People's Republic of China. Hauptthemen laut MEDLINE: Cetuximab, Colorectal Neoplasms, AMP-Activated Protein Kinases, Butyrates. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CetuximabColorectal NeoplasmsAMP-Activated Protein KinasesButyratesAntineoplastic Agents, ImmunologicalHumansErbB ReceptorsSignal TransductionAnimalsCell ProliferationMiceMice, NudeDose-Response Relationship, DrugDrug Screening Assays, AntitumorDrug Resistance, NeoplasmMice, Inbred BALB CTumor Cells, Cultured

Stichwörter der Autor:innen

AMPK/wip1 pathwayEGFR signalingbutyratecetuximab resistancecolorectal cancer

Substanzen

ErbB ReceptorsCetuximabEGFR protein, humanAMP-Activated Protein KinasesButyratesAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • School of Medicine, Nankai University, Tianjin, People's Republic of China.
  • Tianjin Institute of Coloproctology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, People's Republic of China.
  • Department of Colorectal Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, People's Republic of China.
  • Human Biology and Society, University of California, Los Angeles, CA, USA.
  • TEDA Institute of Biological Sciences and Biotechnology, Nankai University, Tianjin, People's Republic of China.
  • Department of Pharmacy, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, People's Republic of China.

ORCID-Profile: Mingqing Zhang, Yijia Wang

Zitieren

APA

Zhang, J., Zhang, M., Wu, X., Jing, H., Li, P., Wang, W., Guo, X., Zhao, Z., Zhu, S., & Wang, Y. (2026). Circulating Butyrate Attenuates Cetuximab Efficacy in Colorectal Cancer Through EGFR and AMPK–Wip1 Signaling. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s574116

Vancouver

Zhang J, Zhang M, Wu X, Jing H, Li P, Wang W, et al. Circulating Butyrate Attenuates Cetuximab Efficacy in Colorectal Cancer Through EGFR and AMPK–Wip1 Signaling. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s574116

BibTeX
@article{Zhang2026,
  author = {Zhang, Jiayao and Zhang, Mingqing and Wu, Xiaojing and Jing, Haoren and Li, Peiran and Wang, Wei and Guo, Xi and Zhao, Zhenying and Zhu, Siwei and Wang, Yijia},
  title = {Circulating Butyrate Attenuates Cetuximab Efficacy in Colorectal Cancer Through EGFR and AMPK–Wip1 Signaling},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s574116}
}
Kostenlos starten →